Tag: AMAG pharmaceuticals

AMAG Pharmaceuticals Announces Topline Results From the PROLONG Trial Evaluating Makena

AMAG Pharmaceuticals (NASDAQ:AMAG) has announced topline results from its PROLONG trial evaluating Makena in patients with a history of a...

AMAG Pharmaceuticals Acquires Orphan Drug Candidate for Treatment of Severe Preeclampsia

AMAG Pharmaceuticals (NASDAQ:AMAG) today announced it has acquired global rights to develop and market digoxin immune Fab (ovine) (DIF), a polyclonal...

5 Top Weekly NASDAQ Biotech Stocks: Eleven Biotherapeutics Up 45 Percent

Eleven Biotherapeutics, EyePoint Pharmaceuticals, Avid Bioservices, Cerecor and Celldex were last week's top gainers on the NASDAQ.

5 Top NASDAQ Biotech Stocks: Cardiome on Top

Cardiome, Avid, XBiotech, Fennec and Compugen were last week's five top-gaining NASDAQ biotech stocks. See what moved their share prices.

AMAG Pharmaceuticals Submits a New Drug Application to the U.S. Food and Drug Administration

AMAG Pharmaceuticals (NASDAQ:AMAG) announced that it has submitted a New Drug Application (NDA) to the U.S. Food and Drug Administration...

5 Top NASDAQ Biotech Stocks: Second Sight Medical on Top

Second Sight, Juniper, Athersys, Aptose and ArQule were last week's five top-gaining NASDAQ biotech stocks. See what moved their share...

5 Top NASDAQ Biotech Stocks: Tenax on top with a 51.94 Percent Increase

This past week the NASDAQ Biotechnology Index increased by 4.15 percent reaching 3,501.80 points in the last week—nearly equal to...